Skip to main content
OpenTrials

Clinical trial condition

Polycythemia Vera

Explore clinical trials studying Polycythemia Vera. Study availability and eligibility vary by location and protocol.

210 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Polycythemia Vera trial results

Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT06661915

Conditions
Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm, Blood Coagulation Disorders, +19 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 31 locations
View Trial Details
Recruiting

A Study of Rusfertide in Japanese Adults With Polycythemia Vera

NCT07648030

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Mie University Hospital Tsu, Mie-ken, Japan
  • University of Osaka Hospital Suita, Osaka, Japan
  • Juntendo University Hospital Bunkyo-ku, Tokyo, Japan
  • University of Yamanashi Hospital Chūō, Yamanashi, Japan
View Trial Details
Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

NCT07469891

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +13 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • BRCR Global - Coral Springs Coral Springs, Florida, United States
  • START Midwest, LLC Grand Rapids, Michigan, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)

NCT06506084

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • SC Ematologia, ASST Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Divisione Ematologia ASST, Grande Ospedale Metropolitano Niguarda Milan, Lombardy, Italy
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
  • U.O. Ematologia, Ospedale di Circolo e Fondazione Macchi Varese Varese, Lombardy, Italy
View all 37 locations
View Trial Details
Recruiting

A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes

NCT07203768

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Bone Marrow Neoplasms, +9 more
Locations
  • Mayo Clinic Rochester, Minnesota, United States
  • University Hospital Halle Halle, Germany
  • Hannover Medical School Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden, Germany
View all 24 locations
View Trial Details
Recruiting

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

NCT07429266

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • Regis Clinical Research LLC. Miami, Florida, United States
  • Florida Clinical Trials Group Plantation, Florida, United States
  • Florida Clinical Trials Group Tamarac, Florida, United States
  • The Center for Cancer & Blood Disorders Bethesda, Maryland, United States
View Trial Details

Related conditions